Eli Lilly's performance in the biopharmaceutical sector reflects its strong market position, despite facing challenges. The ...

Viking Therapeutics (NASDAQ: VKTX) soared into the spotlight about a year ago when it delivered promising data on a drug ...

Metsera's IPO raised $316.2 million, funding its obesity drug MET-097i, which shows promise with once-monthly dosing. Read ...

Global Partners (NYSE:GLP – Get Free Report) is expected to release its earnings data before the market opens on Friday, February 28th. Analysts expect Global Partners to post earnings of $0.24 per ...

This writer noticed that UK stock investors have been buying an obscure share that fell 26% yesterday but is still up nearly ...

The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...

Queer Eye star Jonathan Van Ness has shared their incredible weight loss transformation in a candid post on Instagram, and ...

“Queer Eye” star Jonathan Van Ness recently posted before-and-after photos to show off his drastic weight loss. Van Ness, 37, took to his Instagram Story Sunday to share a shirtless image of himself ...

People who have depended on off-brand versions of Wegovy and Ozempic will likely have to pay more now that a nationwide ...

You've probably seen the ads for GLP-1 drugs. It's a hormone that helps people lose weight, but the results are not ...

Pharmaceutical giant Eli Lilly is once again expanding the supply of its weight-loss drug Zepbound and cutting the cost for patients that don't have insurance.

The Cheesecake Factory, Inc. and Keurig Dr Pepper, Inc. are among businesses warning investors in their annual reports that ...